Literature DB >> 11278606

Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen.

J Iida1, D Pei, T Kang, M A Simpson, M Herlyn, L T Furcht, J B McCarthy.   

Abstract

Tumor cell adhesion and proteolysis of the extracellular matrix proteins surrounding the cells are tightly linked processes in tumor invasion. In this study, we sought to identify components of the cell surface of a vertical growth phase melanoma cell line, WM1341D, that mediate invasive cellular behavior. We determined by antisense inhibition that melanoma chondroitin sulfate proteoglycan (MCSP) and membrane-type 3 matrix metalloproteinase (MT3-MMP) expressed on WM1341D are required for invasion of type I collagen and degradation of type I gelatin. MT3-MMP co-immunoprecipitated with MCSP in WM1341D melanoma cells cultured on type I collagen or laminin. The association between MT3-MMP and MCSP was largely disrupted by removing chondroitin sulfate glycosaminoglycan (CS) from the cell surface, suggesting CS could mediate the association between the two cell surface core proteins. Recombinant MT3-MMP and MT3-MMP from whole cell lysates of WM1341D cells were specifically eluted from CS- conjugated affinity columns. The results indicate that MT3-MMP possesses the potential to promote melanoma invasion and proteolysis and that the formation of a complex between MT3-MMP and MCSP may be a crucial step in activating these processes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278606     DOI: 10.1074/jbc.M010053200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  New approaches to the biology of melanoma: a workshop of the National Institutes of Health Pathology B Study Section.

Authors:  Meenhard Herlyn; Martin Padarathsingh; Lynda Chin; Mary Hendrix; Dorothea Becker; Mark Nelson; Yves DeClerck; James McCarthy; Suresh Mohla
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 2.  NG2-expressing cells in the nervous system: role of the proteoglycan in migration and glial-neuron interaction.

Authors:  Khalad Karram; Nivedita Chatterjee; Jacqueline Trotter
Journal:  J Anat       Date:  2005-12       Impact factor: 2.610

3.  Matrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells.

Authors:  Seiji Goda; Hiroshi Inoue; Hisanori Umehara; Michihiko Miyaji; Yutaka Nagano; Nari Harakawa; Hisao Imai; Peter Lee; James B Macarthy; Takashi Ikeo; Naochika Domae; Yoji Shimizu; Joji Iida
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

4.  Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice.

Authors:  Jae-Hyuk Yi; Yasuhiro Katagiri; Bala Susarla; David Figge; Aviva J Symes; Herbert M Geller
Journal:  J Comp Neurol       Date:  2012-10-15       Impact factor: 3.215

5.  Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A).

Authors:  Joji Iida; Krista L Wilhelmson; Janet Ng; Peter Lee; Charlotte Morrison; Eric Tam; Christopher M Overall; James B McCarthy
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

6.  Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.

Authors:  Fengying Tang; Megan S Lord; William B Stallcup; John M Whitelock
Journal:  J Biochem       Date:  2018-05-01       Impact factor: 3.387

Review 7.  Transduction of extracellular cues into cell polarity: the role of the transmembrane proteoglycan NG2.

Authors:  Fabien Binamé
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

Review 8.  Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.

Authors:  Achilleas D Theocharis; Chrisostomi Gialeli; Panagiotis Bouris; Efstathia Giannopoulou; Spyros S Skandalis; Alexios J Aletras; Renato V Iozzo; Nikos K Karamanos
Journal:  FEBS J       Date:  2014-11-06       Impact factor: 5.542

Review 9.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

10.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.